Nervous Disorder TRIZ Cases

EMDP metabolite blocks neuronal nicotinic acetylcholine receptors, reducing autonomic side effects while treating anxiety.

A small molecule protocol converts human fibroblasts to neural stem cells, avoiding genomic instability and tumorigenesis risks associated with viral vectors.

Transfected cells expressing bone morphogenetic proteins reduce neuronal loss and degeneration induced by cytotoxic agents.

Cocrystals raise API melting points via carboxylic acids, resolving low-melting formulation bottlenecks.

Targeting HERV Env proteins reduces Tau aggregate spreading and enables antemortem diagnosis of tauopathies.

Systemic SCO-Spondin peptides cross blood barriers to treat spinal cord injury while maintaining bioavailability and reducing toxicity.

A MerTK ligand conjugated to an amyloid beta binding protein directs microglial clearance of aggregates.

Chemical modifications enhance in vivo stability and silencing efficiency of double-stranded RNA targeting the Huntingtin gene.

Differentiating human embryonic stem cells through a trophoblast intermediate stage to generate mesenchymal-like stem cells.

Combines levocetirizine and montelukast to suppress inflammation and reduce viral titers in severe infections.

Optimized culture medium formulation using bFGF and CHIR-99021 to drive neuromesodermal stem cell differentiation into functional motor neurons.

Heterocyclic tripeptide epoxyketones inhibit proteasomes to reduce toxicity and overcome drug resistance in tumor treatment.

Specific amino acid substitutions in the Fc region improve FcRn binding, extending serum half-life while maintaining manufacturing simplicity.

Myricanol activates proteasomal and lysosomal degradation to clear toxic soluble tau intermediates that conventional aggregation inhibitors fail to remove.

Derive axial stem cells using CHIR99021 to activate the Wnt pathway and serial passaging in RPMI 1640 medium.

A multi-herb Chinese medicine composition promotes dopaminergic cell proliferation and signal transduction.

Cyclized peptide monomers and dimers achieve selective α4β7 integrin binding, reducing systemic side effects in gastrointestinal autoimmune therapy.

Notum inhibitors block the secreted carboxy esterase Notum to restore Wnt signaling levels for treating neurodegenerative disorders and cancers.

Alkyl ether derivatives promote neuroprotection and regeneration, addressing limited effectiveness in conventional nerve injury rehabilitation.

Bile salt micelles in oral cannabidiol formulations boost steady-state plasma levels while maintaining liver enzyme stability.

Non-self-complementary AAV vectors overcome the blood-brain barrier and accommodate therapeutic genes exceeding two kilobases.

Combining taltirelin with arundic acid regenerates neuronal cells to ameliorate spatial memory impairment in neurodegenerative disease models.

Insulin conjugates link the hormone to saccharide ligands via a synthetic framework to achieve sustained release profiles.

Single-stranded DNA aptamers replace antibodies to target intracellular alpha-synuclein, avoiding blood-brain barrier limits and immunogenicity.

VR-1 agonist liquid supplements stimulate swallow reflexes while reducing pungency and toxicity risks associated with capsaicin troches.

Polypeptides inhibit CXCR7 signaling via specific binding, addressing side effects from small molecule antagonists.

Combines a dopamine stabilizing agent with an anti-depressive agent to treat debilitating fatigue disorders.

Buffering layers neutralize gastric acid to limit abuse potential while maintaining therapeutic efficacy at prescribed doses.

Monoclonal anti-beta-amyloid antibodies bind dimeric Aβ forms with high affinity to enable targeted therapeutic and diagnostic applications.

Selective antibodies bind soluble amyloid beta 1-42 oligomers to block neuronal interaction and reverse cognitive impairment.

Developing crystalline polymorphs, salts, and cocrystals of LX9211 improves stability and bioavailability while managing formulation complexity.

Administering APC carbamate compounds to achieve normal wakefulness levels.

Vax1 protein binds heparan sulfate proteoglycans on retinal ganglion cell axons, overcoming repulsive signals that block midline crossing in the optic chiasm.

Pharmaceutical compositions stabilize anti-beta amyloid antibodies using arginine hydrochloride and thiol-containing antioxidants.

Mutant H-NOX proteins deliver oxygen with reduced nitric oxide reactivity and extended plasma retention, addressing hypertension risks in blood substitutes.

Compound I-127 blocks P2X3 receptors to treat chronic cough without taste disturbances.

Combining PDE5 and acetylcholinesterase inhibitors reduces neuroinflammation and beta-amyloid accumulation to halt disease progression.

Defined oligosialic acid fragments compensate for brain deficiencies, resolving manufacturing precision challenges while treating neurological disorders.

Sialic acid-conjugated antigens enhance dendritic cell uptake to drive naive CD4 T cells into FoxP3+ regulatory T cells.

Molecular tweezers bind amyloid proteins to inhibit aggregation, addressing inadequate enzyme replacement therapy for lysosomal storage disorders.

CaM-KIIN-derived peptides inhibit autonomous CaMKII activity with high specificity, avoiding off-target effects on other kinases.

Segmented retaining elements eliminate manual handling during transfer, preventing germ contamination while ensuring reliable adhesion.

A peptide composition binds to CCNY protein to induce long-term potentiation in synapses.

Recombinant TALEN proteins target specific genomic sequences in neural stem cells to enable precise homologous recombination.

Engineered anti-IL6 antibodies inhibit IL6-induced cell proliferation and angiogenesis, reducing tumor growth while enhancing chemotherapy efficacy.

Mutations eliminate glycosylation sites to boost anti-inflammatory activity without high IVIG doses.

CLA096 blocks TREK-1 potassium channels to overcome slow monoamine onset and treat refractory depression.

A core-shell structure uses a surfactant shell to move hydrophilic drugs through skin barriers.